Canada vs Estonia: Treatment success rate for patients treated for MDR-TB
Canada
87.0%
in 2014
Estonia
88.0%
in 2022
Canada rank
27th
Estonia rank
26th
Treatment success rate for patients treated for MDR-TB over time
- Canada
- Estonia
How they compare
Estonia currently reports 88.0% against 87.0% in Canada, a difference of 1.0%.
The two have swapped places 3 times across 8 shared years of data; in 2007 it was Estonia ahead.
Canada ranks 27th and Estonia ranks 26th of 163 countries.
Canada has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Canada | Estonia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 56.7% | 46.0% | 10.7% | Canada |
| 2010s | 79.4% | 65.6% | 13.8% | Canada |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Canada or Estonia?
- Estonia, at 88.0% against 87.0% in Canada as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Canada and Estonia?
- 1.0%, with Estonia ahead.
- How many years of comparable data are there for Canada and Estonia?
- 8 years are reported by both, from 2007 to 2014.
- How do Canada and Estonia rank globally for treatment success rate for patients treated for mdr-tb?
- Canada ranks 27th and Estonia ranks 26th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.